“Deep Sepsis” Licensed to Cohere Med
Cohere Med licenses technology from Duke to drive adoption of early Sepsis detection using AI PRESS RELEASE: 3 JULY 2019 Sepsis strikes more than a million Americans every year and 15 to 30 percent…
Phitonex Launches NovaFluor Dyes Enabling High-Res Analysis
Phitonex, Inc. launched their new suite of NovaFluor dyes today at CYTO2019, the 34th Congress of the International Society for Advancement of Cytometry, the largest industry conference in single cell biology. New dyes developed on…
Enzyvant Announces FDA Acceptance of Biologics License Application
Enzyvant Announces FDA Acceptance of Biologics License Application (BLA) and Priority Review Status for RVT-802, a Novel Investigational Tissue-Based Regenerative Therapy for Pediatric Congenital Athymia CAMBRIDGE, Mass. & BASEL, Switzerland–(BUSINESS WIRE)–Enzyvant, a biopharmaceutical company focused…
Enzyvant: FDA Acceptance of Biologics License Application
Enzyvant Announces FDA Acceptance of Biologics License Application (BLA) and Priority Review Status for RVT-802, a Novel Investigational Tissue-Based Regenerative Therapy for Pediatric Congenital Athymia —RVT-802, a one-time therapy, leverages Enzyvant’s T cell generation platform…
New Ag Tool: Plant Hormone that Speeds Root Growth
Scientists have identified a plant hormone, beta-cyclocitral, that makes tomato and rice plant roots grow faster and branch more. The hormone could help farmers enhance crop plant growth. A molecule sold as a food additive…
Venture Day Showcased 8 Duke Start-ups in Biotech & Therapeutics
On Wednesday, May 1st, over a dozen venture capital firms gathered for the first Duke Venture Day at the newly refurbished Chesterfield Building in downtown Durham. The day-long event showcased therapeutic innovations currently coming out…
HARVEY Helps Move Bioprinted Organs Closer to Reality
Supercomputer code successfully models behavior of interwoven vasculature created with new 3D printing technique Bioprinting research from the lab of Rice University bioengineer Jordan Miller featured a visually stunning proof-of-principle — a scale-model of a…
Lab-grown tissue patch could fix ailing hearts
Every 40 seconds, someone in the United States has a heart attack. Each time, up to a billion heart muscle cells suffocate. Those lost cells never regrow, leaving almost 800,000 people a year impaired for…
PhaseBio’s Latest FDA Designation Moves It One Step Closer To Potential Approval
PhaseBio Pharmaceuticals has made substantial progress the last few weeks in terms of creating a buzz around its stock. Its phase 1 study showed that its drug PB2452 had made a sharp and quick reversal…